Bill
Bill > HB2557
summary
Introduced
01/09/2019
01/09/2019
In Committee
02/07/2019
02/07/2019
Crossed Over
02/11/2019
02/11/2019
Passed
02/15/2019
02/15/2019
Dead
Signed/Enacted/Adopted
03/05/2019
03/05/2019
Introduced Session
2019 Regular Session
Bill Summary
Drug Control Act; Schedule V; gabapentin. Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Administration shall have until July 1, 2020, or within six months of final approval of compliance from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier, to comply with storage requirements for Schedule V controlled substances containing gabapentin.
AI Summary
This bill classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern, but this bill removes the list of drugs of concern from the Code of Virginia. The bill also provides a grace period for wholesale drug distributors to comply with the new storage requirements for Schedule V controlled substances containing gabapentin, giving them until July 1, 2020, or within 6 months of final approval from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Governor: Acts of Assembly Chapter text (CHAP0214) (on 03/05/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...